ahlam1399
04-17-2016, 12:11 PM
WASHINGTON: An experimental once-daily combination hepatitis C treatment being developed by AbbVie Inc demonstrated very high cure rates across a wide range of disease ge**types, according to data presented on Saturday, likely giving the company a...http://feeds.feedburner.com/~r/com/YEor/~4/S9pN7gkMd6c
أكثر... (http://feedproxy.google.com/~r/com/YEor/~3/S9pN7gkMd6c/113378-New-hepatitis-C-regimen-shows-high-cure-rates-studies)
أكثر... (http://feedproxy.google.com/~r/com/YEor/~3/S9pN7gkMd6c/113378-New-hepatitis-C-regimen-shows-high-cure-rates-studies)